CompletedPHASE1, PHASE2NCT01913340

Neonatal Erythropoietin And Therapeutic Hypothermia Outcomes in Newborn Brain Injury (NEATO)

Studying Neonatal hypoxic and ischemic brain injury

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University of California, San Francisco
Principal Investigator
Yvonne W Wu, MD, MPH, MSN, DNP, FNP-C
University of California, San Francisco
Intervention
Erythropoietin(drug)
Enrollment
50 target
Eligibility
All sexes
Timeline
20132016

Study locations (7)

Collaborators

Thrasher Research Fund · Seattle Children's Hospital · Arkansas Children's Hospital Research Institute · Washington University School of Medicine · Children's National Research Institute · Stanford University · Kaiser Permanente

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01913340 on ClinicalTrials.gov

Other trials for Neonatal hypoxic and ischemic brain injury

Additional recruiting or active studies for the same condition.

See all trials for Neonatal hypoxic and ischemic brain injury

← Back to all trials